TR199802351T2 - Anti-vaginitis composition containing one or more local anesthetics and anti-vaginitis agents for topical use. - Google Patents

Anti-vaginitis composition containing one or more local anesthetics and anti-vaginitis agents for topical use.

Info

Publication number
TR199802351T2
TR199802351T2 TR1998/02351T TR9802351T TR199802351T2 TR 199802351 T2 TR199802351 T2 TR 199802351T2 TR 1998/02351 T TR1998/02351 T TR 1998/02351T TR 9802351 T TR9802351 T TR 9802351T TR 199802351 T2 TR199802351 T2 TR 199802351T2
Authority
TR
Turkey
Prior art keywords
vaginitis
agents
local anesthetics
topical use
composition containing
Prior art date
Application number
TR1998/02351T
Other languages
Turkish (tr)
Inventor
Embil Koral
Morton Oswald
Original Assignee
Edko Trading And Representation Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10793879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR199802351(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Edko Trading And Representation Company Limited filed Critical Edko Trading And Representation Company Limited
Publication of TR199802351T2 publication Critical patent/TR199802351T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Vajinit tedavisinde topikal olarak kullanilmaya mahsus bir farmasötik bilesimi olup, metronizazol ve mikonazol gibi bir veya daha fazla anti-vajinit ilaç ve lidokain veya benzokarin gibi bir veya daha fazla lokal aneztezik içerir.A pharmaceutical composition for topical use in the treatment of vaginitis, containing one or more anti-vaginitis drugs such as metronizazole and miconazole, and one or more local anesthetics such as lidocaine or benzocarin.

TR1998/02351T 1996-05-17 1997-05-16 Anti-vaginitis composition containing one or more local anesthetics and anti-vaginitis agents for topical use. TR199802351T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9610359.3A GB9610359D0 (en) 1996-05-17 1996-05-17 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
TR199802351T2 true TR199802351T2 (en) 1999-03-22

Family

ID=10793879

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/02351T TR199802351T2 (en) 1996-05-17 1997-05-16 Anti-vaginitis composition containing one or more local anesthetics and anti-vaginitis agents for topical use.

Country Status (12)

Country Link
EP (1) EP0910377A1 (en)
JP (1) JP2000513334A (en)
CN (1) CN1127338C (en)
AU (1) AU2905597A (en)
BR (1) BR9709316A (en)
GB (1) GB9610359D0 (en)
ID (1) ID16929A (en)
MY (1) MY127711A (en)
RU (1) RU2195281C2 (en)
TR (1) TR199802351T2 (en)
WO (1) WO1997044032A1 (en)
ZA (1) ZA974266B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777783A1 (en) * 1998-04-24 1999-10-29 Innothera Lab Sa Pharmaceutical composition for treatment of infectious vulvovaginitis and vaginosis
US5993836A (en) * 1998-04-28 1999-11-30 Castillo; James G. Topical anesthetic formulation
TWI232111B (en) * 1999-08-06 2005-05-11 Upjohn Co Intravaginal clindamycin ovule composition
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US20050095245A1 (en) 2003-09-19 2005-05-05 Riley Thomas C. Pharmaceutical delivery system
US8309103B2 (en) * 2004-01-22 2012-11-13 Alparis, S.A. De C.V. Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage
GB0405406D0 (en) * 2004-03-10 2004-04-21 Edko Pazarlama Tanitim Ltd Sti Anti-vaginitis compositions
CA2605341A1 (en) * 2005-05-09 2006-11-16 Drugtech Corporation Modified-release pharmaceutical compositions
CN1291754C (en) * 2005-07-12 2006-12-27 李赴朝 Localized anesthesia synergistic delay agent
CN101365425A (en) * 2006-01-05 2009-02-11 药物技术公司 Drug delivery system for bioadhesion to a vulvovaginal surface
BRPI0620908A2 (en) * 2006-01-05 2011-11-29 Drugtech Corp pharmaceutical composition, vaginal antibacterial and antifungal delivery system and use of pharmaceutical composition
RU2603490C1 (en) * 2015-11-30 2016-11-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Agent for treating pyoinflammatory processes in soft tissues and mucous membranes
RU2605343C1 (en) * 2015-11-30 2016-12-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Agent for treating pyoinflammatory processes in soft tissues and mucous membranes
RS62022B1 (en) 2016-07-08 2021-07-30 Acraf Pharmaceutical composition comprising benzydamine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830405D0 (en) * 1988-12-30 1989-03-01 Embil Koral Pharmaceutical formulation

Also Published As

Publication number Publication date
RU2195281C2 (en) 2002-12-27
MY127711A (en) 2006-12-29
CN1223581A (en) 1999-07-21
ID16929A (en) 1997-11-20
CN1127338C (en) 2003-11-12
GB9610359D0 (en) 1996-07-24
WO1997044032A1 (en) 1997-11-27
EP0910377A1 (en) 1999-04-28
ZA974266B (en) 1998-11-16
JP2000513334A (en) 2000-10-10
BR9709316A (en) 2000-05-02
AU2905597A (en) 1997-12-09

Similar Documents

Publication Publication Date Title
ATE162945T1 (en) AGENTS FOR TRANSDERMAL APPLICATION CONTAINING 3-KETO-DESOGESTREL
TR199801501T1 (en) New formulation.
TR199802351T2 (en) Anti-vaginitis composition containing one or more local anesthetics and anti-vaginitis agents for topical use.
DE69905170T2 (en) THIAZOLOPYRIMIDINDERIVATE
TR200100054T2 (en) Paroxetine methanesulfonate
DE69531098D1 (en) PIPERIDINE AND PYRROLIDINE
EE9700044A (en) Heteroaryloxazolidinones, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds.
MXPA97002401A (en) Antiinflammatory agent for external use.
IT1285770B1 (en) CORTICOID COMPOUNDS
ATE212829T1 (en) SOLID ANHYDROUS PHARMACEUTICAL PREPARATIONS FOR VAGINAL USE
SE9802937D0 (en) Novel compounds
BR9807523A (en) Quinoxalins in triple combination with protease inhibitors and reverse transcriptase inhibitors as drugs for the treatment of AIDS.
RS49599B (en) Use of h+, k+ -atpaze inhibitors and glucocortifoids and pharmaceutical formulation
FR2713444B1 (en) Liquid disinfectant composition and uses thereof.
DK1135169T3 (en) Use of a pharmaceutical composition containing an anticancer agent and at least one peptide.
ZA949874B (en) B3-adrenergic agents, benzodioxole dicarboxylates and their use in pharmaceutical compositions.
TR199501553A2 (en) Sefem compounds and their use as pharmaceuticals.
BR9802803A (en) action and pharmaceutical compositions containing them.
ATE218881T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING MUTATED TYROSINE 353 EZRINE
NZ525774A (en) Use of SARP-1 for the treatment and/or prevention of scleroderma
ES2126760T3 (en) NEW ANSIOLYTIC.
DE59811656D1 (en) Kombinationspräparat aus 2-methylthiazolidin-2,4-dicarbonsäure und paracetamol
ES2152315T3 (en) XAMONELINE TARTRATO.
ES2196769T3 (en) TOPICAL USE OF LOPERAMIDE FOR THE TREATMENT OF MICROBIAL INFECTIONS.
IT1265647B1 (en) TOPICAL PHARMACEUTICAL COMPOSITION FOR RESPIRATORY ALLERGIES